Found: 321
Select item for more details and to access through your institution.
Comment on Pulmonary Hypertension in a Patient with Congenital Heart Defects and Heterotaxy Syndrome.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Neurally adjusted ventilatory assist versus conventional ventilation in the pediatric population: Are there benefits?
- Published in:
- Pediatric Pulmonology, 2019, v. 54, n. 9, p. 1374, doi. 10.1002/ppul.24413
- By:
- Publication type:
- Article
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.
- Published in:
- European Radiology, 2024, v. 34, n. 6, p. 3882, doi. 10.1007/s00330-023-10441-5
- By:
- Publication type:
- Article
MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T.
- Published in:
- European Radiology, 2022, v. 32, n. 5, p. 2937, doi. 10.1007/s00330-021-08381-z
- By:
- Publication type:
- Article
Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease.
- Published in:
- European Radiology, 2022, v. 32, n. 4, p. 2457, doi. 10.1007/s00330-021-08369-9
- By:
- Publication type:
- Article
Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
- Published in:
- European Radiology, 2021, v. 31, n. 11, p. 8408, doi. 10.1007/s00330-021-07988-6
- By:
- Publication type:
- Article
Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Inter-sonographer reproducibility of quantitative ultrasound outcomes and shear wave speed measured in the right lobe of the liver in adults with known or suspected non-alcoholic fatty liver disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder.
- Published in:
- Frontiers in Physiology, 2020, v. 11, p. 1, doi. 10.3389/fphys.2020.00370
- By:
- Publication type:
- Article
Isomerism: When right and left are similar, and why it matters.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status.
- Published in:
- 2009
- By:
- Publication type:
- journal article
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 7, p. 2430, doi. 10.1007/s10620-024-08437-2
- By:
- Publication type:
- Article
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 1, p. 40, doi. 10.3390/ijms22010040
- By:
- Publication type:
- Article
Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 1, p. 1, doi. 10.1007/s00520-022-07525-1
- By:
- Publication type:
- Article
Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases.
- Published in:
- Annals of Laboratory Medicine, 2021, v. 41, n. 1, p. 16, doi. 10.3343/alm.2021.41.1.16
- By:
- Publication type:
- Article
MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1351, doi. 10.1111/apt.18236
- By:
- Publication type:
- Article
Editorial: Cardiometabolic criteria matters in MASLD—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 8, p. 1033, doi. 10.1111/apt.18205
- By:
- Publication type:
- Article
Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 4, p. 484, doi. 10.1111/apt.18118
- By:
- Publication type:
- Article
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 3, p. 369, doi. 10.1111/apt.18099
- By:
- Publication type:
- Article
Editorial: Has MetALD met the presumption? Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Randomised clinical trial: Design of the SYNERGY‐NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction‐associated steatohepatitis and modification of screening strategy to reduce screen failures.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 1, p. 17, doi. 10.1111/apt.18042
- By:
- Publication type:
- Article
Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 1, p. 61, doi. 10.1111/apt.18015
- By:
- Publication type:
- Article
A prospective study on the prevalence of at‐risk MASH in patients with type 2 diabetes mellitus in the United States.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 12, p. 1571, doi. 10.1111/apt.17997
- By:
- Publication type:
- Article
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 12, p. 1521, doi. 10.1111/apt.17981
- By:
- Publication type:
- Article
Monitoring disease progression in metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. S41, doi. 10.1111/apt.17752
- By:
- Publication type:
- Article
Editorial: Crystalising the burden of steatotic liver disease—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1183, doi. 10.1111/apt.17967
- By:
- Publication type:
- Article
Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1271, doi. 10.1111/apt.17958
- By:
- Publication type:
- Article
Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 9, p. 1049, doi. 10.1111/apt.17948
- By:
- Publication type:
- Article
Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 6, p. 730, doi. 10.1111/apt.17888
- By:
- Publication type:
- Article
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 5, p. 666, doi. 10.1111/apt.17849
- By:
- Publication type:
- Article
Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 150, doi. 10.1111/apt.17846
- By:
- Publication type:
- Article
Letter: Are we forgetting the importance of steatosis in steatotic liver disease? Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
A Message from the Editors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 4, doi. 10.1111/apt.17797
- By:
- Publication type:
- Article
Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 80, doi. 10.1111/apt.17783
- By:
- Publication type:
- Article
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 51, doi. 10.1111/apt.17734
- By:
- Publication type:
- Article
Editorial: Can liver fat quantification stratify cardiovascular risk in type 2 diabetes? Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
MEFIB‐Index and MAST‐Score in the assessment of hepatic decompensation in metabolic dysfunction‐associated steatosis liver disease—Individual participant data meta‐analyses.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 9, p. 856, doi. 10.1111/apt.17707
- By:
- Publication type:
- Article
Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy‐confirmed nonalcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 10, p. 1005, doi. 10.1111/apt.17709
- By:
- Publication type:
- Article
The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 10, p. 1062, doi. 10.1111/apt.17714
- By:
- Publication type:
- Article
Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 6, p. 585, doi. 10.1111/apt.17637
- By:
- Publication type:
- Article
Editorial: Will MRI‐PDFF become the new standard for steatosis assessment in NAFLD? Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI‐PDFF in NAFLD.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 2, p. 229, doi. 10.1111/apt.17564
- By:
- Publication type:
- Article
Meta‐analysis: Prevalence of significant or advanced fibrosis in adults with alpha‐1‐antitrypsin deficiency.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 2, p. 152, doi. 10.1111/apt.17516
- By:
- Publication type:
- Article
Available modalities for screening and imaging diagnosis of hepatocellular carcinoma--Current gaps and challenges.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1056, doi. 10.1111/apt.17506
- By:
- Publication type:
- Article